NCT07346222

Brief Summary

The general objective of this study is to deepen the knowledge of patients affected by endocarditis.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
418

participants targeted

Target at P75+ for all trials

Timeline
55mo left

Started Aug 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Aug 2020Nov 2030

Study Start

First participant enrolled

August 20, 2020

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 13, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 8, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 16, 2026

Completed
4.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 13, 2030

Expected
Last Updated

January 16, 2026

Status Verified

December 1, 2025

Enrollment Period

5.2 years

First QC Date

January 8, 2026

Last Update Submit

January 8, 2026

Conditions

Endocarditis Infective

Outcome Measures

Primary Outcomes (1)

  • describes the characteristics and clinical course that correlate with an adverse clinical outcome.

    2029

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This is a study conducted on the population affected by endocarditis admitted to the wards of our hospital and observational, i.e. having the sole aim of describing the characteristics of this type of critically ill patients.

You may qualify if:

  • All patients admitted from 1stJannary 2009 to 31 Dec 2029 to the Fondazione IRCCS Policlinico San Matteo with a diagnosis of IE according to modified Duke criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione IRCCS Policlinico San Matteo di Pavia

Pavia, Lombardy, 27100, Italy

RECRUITING

MeSH Terms

Conditions

Endocarditis

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Central Study Contacts

Elena Maria Seminari

CONTACT

+39 0382 502646E.Seminari@smatteo.pv.it

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
OTHER
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 8, 2026

First Posted

January 16, 2026

Study Start

August 20, 2020

Primary Completion

November 13, 2025

Study Completion (Estimated)

November 13, 2030

Last Updated

January 16, 2026

Record last verified: 2025-12

Locations

IT(1)